BioNexus Gene Lab Corp (BGLC)
0.5721
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.5721
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Enterprise Value: 4.210M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 4.210M |
| May 16, 2024 | 4.141M |
| May 15, 2024 | 4.318M |
| May 14, 2024 | 4.369M |
| May 13, 2024 | 4.320M |
| May 10, 2024 | 4.323M |
| May 09, 2024 | 4.583M |
| May 08, 2024 | 4.495M |
| May 07, 2024 | 4.640M |
| May 06, 2024 | 4.581M |
| May 03, 2024 | 4.742M |
| May 02, 2024 | 4.841M |
| May 01, 2024 | 4.926M |
| April 30, 2024 | 5.023M |
| April 29, 2024 | 4.671M |
| April 26, 2024 | 4.556M |
| April 25, 2024 | 4.540M |
| April 24, 2024 | 4.583M |
| April 23, 2024 | 4.353M |
| April 22, 2024 | 5.025M |
| April 19, 2024 | 4.668M |
| April 18, 2024 | 9.064M |
| April 17, 2024 | 5.260M |
| April 16, 2024 | 5.201M |
| April 15, 2024 | 5.055M |
| Date | Value |
|---|---|
| April 12, 2024 | 5.784M |
| April 11, 2024 | 5.890M |
| April 10, 2024 | 5.466M |
| April 09, 2024 | 5.083M |
| April 08, 2024 | 5.201M |
| April 05, 2024 | 5.413M |
| April 04, 2024 | 5.095M |
| April 03, 2024 | 4.548M |
| April 02, 2024 | 4.760M |
| April 01, 2024 | 5.201M |
| March 28, 2024 | 6.544M |
| March 27, 2024 | 6.438M |
| March 26, 2024 | 6.403M |
| March 25, 2024 | 6.827M |
| March 22, 2024 | 6.880M |
| March 21, 2024 | 7.406M |
| March 20, 2024 | 8.099M |
| March 19, 2024 | 6.882M |
| March 18, 2024 | 7.127M |
| March 15, 2024 | 6.712M |
| March 14, 2024 | 6.597M |
| March 13, 2024 | 6.654M |
| March 12, 2024 | 7.104M |
| March 11, 2024 | 7.712M |
| March 08, 2024 | 7.710M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.2753M
Minimum
Nov 13 2023
404.71M
Maximum
Mar 03 2021
176.87M
Average
183.06M
Median
Enterprise Value Benchmarks
| Balchem Corp | 5.294B |
| Friedman Industries Inc | 170.04M |
| Solitario Resources Corp | 66.84M |
| Golden Minerals Co | 4.429M |
| Paramount Gold Nevada Corp | 36.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.3085M |
| Revenue (Quarterly) | 2.273M |
| Total Expenses (Quarterly) | 2.015M |
| EPS Diluted (Quarterly) | 0.0096 |
| Gross Profit Margin (Quarterly) | 11.73% |
| Profit Margin (Quarterly) | 13.57% |
| Earnings Yield | -30.64% |
| Normalized Earnings Yield | -30.64 |